AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE in Zimbabwe
3 products registered with MCAZ — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2021/7.13/6093 | LAURUS LABS LIMITED | active | 19 Apr 2031 |
| EFAVIRENZ; LAMIVUDINE ; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2023/7.13/6449 | HETERO LABS LTD | active | 20 Jul 2028 |
| EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2021/7.13/6210 | LAURUS LABS LIMITED | active | 31 Dec 2027 |
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 3 registered products containing EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE, of which 3 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.